Tenaya Therapeutics (TNYA) Current Leases (2021 - 2026)
Tenaya Therapeutics (TNYA) posted quarterly Current Leases of $3.1 million for Q1 2026, up 11.49% year-over-year from $2.8 million in Q1 2025, and up 3.15% quarter-over-quarter from $3.0 million in Q4 2025.
Tenaya Therapeutics (TNYA) Current Leases (2021 - 2026) Analysis & Trends
Tenaya Therapeutics' Current Leases history runs 6 years deep, the most recent figure standing at $3.1 million for Q1 2026.
- In Q1 2026, Current Leases rose 11.49% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (up 11.49% YoY), while the FY2025 annual figure was $3.0 million, up 8.71% from the prior year.
- Current Leases for Q1 2026 stood at $3.1 million, up from $3.0 million in the prior quarter.
- The five-year high for Current Leases was $4.3 million in Q4 2023, with the low at $2.1 million in Q1 2022.
- The 5-year median for Current Leases is $3.2 million (2023), against an average of $3.3 million.
- The sharpest annual moves came in 2022 and 2024: Current Leases soared 138.0% in 2022, then sank 35.68% in 2024.
- Tenaya Therapeutics' Current Leases stood at $4.0 million in 2022, then climbed by 7.81% to $4.3 million in 2023, then sank by 35.68% to $2.8 million in 2024, then advanced by 8.71% to $3.0 million in 2025, then advanced by 3.15% to $3.1 million in 2026.
- Business Quant data shows TNYA's Current Leases at $3.1 million in Q1 2026, $3.0 million in Q4 2025, and $2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tenaya Therapeutics | 151.50 Mn | 151.50 Mn | - | 2.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.88 Mn |
| Mar 31, 2026 | 3.12 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 2.93 Mn |
| Jun 30, 2025 | 2.83 Mn |
| Mar 31, 2025 | 2.79 Mn |
| Dec 31, 2024 | 2.78 Mn |
| Sep 30, 2024 | 3.01 Mn |
| Jun 30, 2024 | 3.36 Mn |
| Mar 31, 2024 | 4.06 Mn |
| Dec 31, 2023 | 4.32 Mn |
| Sep 30, 2023 | 3.15 Mn |
| Jun 30, 2023 | 3.45 Mn |
| Mar 31, 2023 | 3.73 Mn |
| Dec 31, 2022 | 4.01 Mn |
| Sep 30, 2022 | 4.02 Mn |
| Jun 30, 2022 | 3.90 Mn |
| Mar 31, 2022 | 2.08 Mn |
| Dec 31, 2021 | 1.99 Mn |
| Sep 30, 2021 | 1.91 Mn |